SCHEMBL6518977

SCHEMBL6518977

Cc1nccc(OC(C)C)c1C(=O)OC(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.45
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA7 P43166 3/20 0.45
CA9 Q16790 3/20 0.45
CA14 Q9ULX7 3/20 0.45
JMJD6 Q6NYC1 1/20 0.38
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
TP53 P04637 1/20 0.36
ALDH1A1 P00352 5/20 0.36
ACHE P22303 1/20 0.36
MAPK1 P28482 1/20 0.36
MAPK10 P53779 1/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 1/20 0.35
KMO O15229 1/20 0.35
IRAK4 Q9NWZ3 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31214501 0.88 LMNA (0.38) CA12CA1CA2CA7CA9
SCHEMBL14649881 0.82 CA12 (0.49) CA12CA1CA2CA7CA9
SCHEMBL13531220 0.74 CA12 (0.50) CA12CA1CA2CA7CA9
SCHEMBL23364634 0.74 CA1 (0.56) CA12CA1CA2CA7CA9
SCHEMBL1326978 0.73 ALDH1A1 (0.41) CA12CA1CA2CA7CA9
SCHEMBL27849283 0.72 KMO (0.43) ALDH1A1ACHELMNAKMOIRAK4
SCHEMBL26049785 0.72 LRRK2 (0.38) POLBKMOIRAK4
SCHEMBL30601101 0.71 MET (0.39) CA12CA1CA2CA7CA9
SCHEMBL17729466 0.71 CA12 (0.41) CA12CA1CA2CA7CA9
SCHEMBL31150976 0.70 CA12 (0.41) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565452-A2 3-SUBSTITUTED-6-ARYL PYRIDINES AS LIGANDS OF C5A RECEPTORS NEUROGEN CORPORATION (US) 2005-08-24 EP disclosed
WO-2004043925-A2 3-SUBSTITUTED-6-ARYL PYRIDINED AS LIGANDS OF C5A RECEPTORS NEUROGEN CORPORATION (US) 2004-05-27 WO disclosed